Diverging Paths: How US, EU, and China are Accelerating AI Adoption in Healthcare – Enriched Analysis

In early 2025, a flurry of AI healthcare announcements—from FDA approvals in the US to EU funding initiatives and Chinese…

Quantum Computing’s Regulatory Maze: How Regional Policies Are Defining the Race for Quantum Advantage – Enhanced Analysis

Analysis enriched with additional references and recent market data, highlighting regulatory barriers in the U.S., EU, and China, and their…